Market Update Market Downs as Investors Digest What Dermata DRMAW flagged as biggest challenges ahead DRMAW Q3 Earnings Dermata Warrant Reports No Revenue or Earnings Data JXG JX delivers 565 percent year over year Q1 2025 revenue growth as shares hold steady Why Reitar RITR might be the best kept secret in the market Momentum Fading 20260511